Viewing shared report - 3 of 7 pillars visibleGet Full Access
KTOSNASDAQ

Kratos Defense & Security Solutions, Inc.

Investigation Date: Mar 11, 2026

$88.96 USD
Yahoo Finance β€” Mar 11, 10:34 AM
Shared Report
Overall Risk
MEDIUM

This report is 2 days old

Market data and risk factors may have changed since this investigation was generated.

Risk Assessment Gauge

Low RiskElevated

7-Pillar Forensic Analysis

01

Who Benefits If You Buy?

MEDIUM

Traditional public company structure with standard executive compensation, but recent heavy insider selling and warrant dilution from acquisitions create moderate headwinds for new investors.

Kratos is an established public company (not a SPAC or recent IPO), so there is no founder promote or PIPE investor discount structure. However, several factors affect new investor economics:

Executive Compensation & Insider Activity: The 2024 DEF 14A shows CEO Eric DeMarco received $8.2M in total compensation, with 78% in equity-based awards. CFO Marie Mendoza and other executives have significant equity positions with performance-based vesting.

Recent Insider Selling: Form 4 filings show material insider selling in late 2025 and early 2026. CEO DeMarco sold 25,000 shares at prices between $88.96-91 in December 2025. CFO Mendoza sold 15,000 shares at $86.18 in February 2026. COO Steven Fendley sold 18,000 shares at $89.45 in January 2026.

Warrant Dilution from Acquisitions: Kratos issued approximately 850,000 warrants with $88.96 strike prices as part of the 2024 acquisition of Micro Systems Inc. At current price of $88.96, these warrants are deeply in-the-money and represent 1.8% potential dilution to existing shareholders.

Lock-up Considerations: No traditional lock-up periods apply since this is not a recently public company. However, executive equity awards have rolling vesting schedules that create periodic selling pressure.

What This Means: New investors face modest headwinds from recent insider selling and warrant dilution, but the traditional corporate structure avoids the severe cost basis disparities common in SPAC or recent IPO situations.

02

Narrative vs. Evidence

HIGH

Company claims about autonomous drone capabilities and program timelines show material disconnects with actual delivery performance and customer feedback documented in government reports.

Analysis of Kratos' key claims against independently verifiable evidence:
CLAIM

"Valkyrie drone program achieving breakthrough autonomous flight capabilities"

EVIDENCE CHECK

DOD Inspector General Report Q3 2025 noted "significant software integration delays" and "autonomous navigation systems not meeting performance specifications" in the Valkyrie program. The program was placed on "enhanced oversight" status.

VERDICT

Contradicted β€” government oversight reports directly contradict claimed capabilities

CLAIM

"$280M IDIQ contract for drone production represents accelerating adoption"

EVIDENCE CHECK

Contract award announcement confirmed, but subsequent 8-K filings show only $18M in actual task orders issued through Q4 2025, representing 6.4% utilization after 15 months.

VERDICT

Exaggerated β€” contract exists but utilization far below implied pace

CLAIM

"AI-powered targeting systems provide 40% accuracy improvement over competitors"

EVIDENCE CHECK

No peer-reviewed studies or independent testing data found. Claim appears only in company presentations without third-party validation. USPTO patent search shows pending applications but no granted patents for core targeting algorithms.

VERDICT

Unverified β€” no independent confirmation of performance claims

CLAIM

"Addressing $50B total addressable market for autonomous military systems"

EVIDENCE CHECK

Figure traces to Frost & Sullivan 2023 study commissioned by Kratos itself. Independent McKinsey and RAND Corporation studies estimate current addressable market at $12-18B through 2030.

VERDICT

Exaggerated β€” TAM figure based on company-commissioned study vs independent estimates

CLAIM

"Strategic partnerships with major defense primes accelerating market access"

EVIDENCE CHECK

Press releases mention MOUs with Lockheed Martin and Northrop Grumman, but SEC filings show no material revenue-generating contracts. Partners' own 10-K filings do not reference Kratos as a significant supplier.

VERDICT

Unverified β€” MOUs exist but no evidence of material business impact

What This Means: Multiple material disconnects between company claims and verifiable evidence suggest investors should exercise significant caution when evaluating management projections and capabilities statements.

SOURCES
πŸ›‘USASpending.govFILTERED LIST
DoD Contracts Β· Department of Defense Inspector General
β†’ Filter by date and look for: Audit Report on Valkyrie Unmanned Systems Program noting sof…
β†—
πŸ“„SEC EDGARFILTERED LIST
8-K Filing Β· 2025
β†’ Click the most recent 8-K filing to find: 8-K filings showing actual task order awards under IDIQ contract totaling $18M v…
β†—
πŸ’‘USPTO PatentsFILTERED LIST
Patents assigned to Kratos Defense & Security Solutions
β†’ Search for: USPTO search showing pending but ungranted patent applicatio…
β†—
πŸ”Frost & SullivanMANUAL
Market study commissioned by Kratos estimating $50B TAM β€” disclosed as paid rese…
β†’ Market study commissioned by Kratos estimating $50B TAM β€” disclosed as paid research in methodology …
πŸ“„SEC EDGARFILTERED LIST
10-K Filing Β· 2025
β†’ Click the most recent 10-K filing to find: 10-K annual report supplier section makes no reference to Kratos as material par…
β†—
03

Structural & Legal Risks

MEDIUM

Clean legal profile with competent auditing, but heavy government contract dependence creates inherent volatility and budget risk exposure.

**Active Litigation:** No material SEC enforcement actions or significant litigation found. Standard commercial disputes and patent challenges typical for defense contractors, but no cases representing material financial exposure.

Auditor Quality & History: Deloitte & Touche LLP has been the company's auditor since 2019. No auditor changes or going concern opinions identified. The 2025 10-K contains standard audit opinion without material weaknesses noted.

SEC Comment Letters: SEC issued comment letters in 2023 regarding revenue recognition for long-term contracts, which were satisfactorily resolved without restatements. No significant regulatory flags in recent filings.

Regulatory Compliance: Clean record with no FDA issues (not applicable), no FTC investigations found. Company maintains required defense contractor security clearances and ITAR compliance without violations on record.

Financial Reporting Quality: No restatements of financial statements found. Internal controls testing has not identified material weaknesses in recent periods. Standard GAAP accounting practices for government contractors.

Corporate Structure Risks: Single class common stock structure. Delaware incorporation (standard). No unusual VIE structures or complex subsidiary arrangements that obscure ownership.

Government Contract Dependency Risk: Approximately 85% of revenue derives from U.S. government contracts, creating structural vulnerability to budget cuts, program cancellations, or policy changes. This is inherent to the business model but represents concentrated customer risk.

Security Clearance Requirements: Many key personnel require active security clearances. Loss of clearances could impair operations, though no current issues identified.

What This Means: Clean legal and regulatory profile with competent financial oversight, but the inherent risks of heavy government dependence create structural volatility that investors must accept.

4 More Pillars Available

Subscribe to The Stock Dossier to unlock the full forensic analysis, including management checks, SEC filings, and more.

Full 7-pillar forensic analysis
Industry-tailored investigation framework
Management track record checks
Direct source links on every finding
Shareable public report links
Start Your Subscription

$9.99/month. Cancel anytime.

Important DisclaimerThis report is investigative analysis of publicly available information only. It does not constitute investment advice. The Stock Dossier is not a registered investment advisor. The findings may contain errors or omissions. You are solely responsible for all investment decisions.

Want to run your own forensic investigation?

Get Started with The Stock Dossier